Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. scores highest on Torque (93) and lowest on Price (0). Its PosiPenta is 55.33 out of 100, around the middle of similar companies.
On the Penta Grid this week, Atara Biotherapeutics, Inc. is Grid #208 of 837 in the Healthcare sector in United States, and Grid #1,215 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 55.33 | 0 | 67 | 53 | 93 | 63 |
| ImmuCell Corporation | 54.18 | 23 | 40 | 90 | 56 | 63 |
| NeurAxis, Inc. | 48.34 | 5 | 59 | 86 | 41 | 50 |
| Park Dental Partners, Inc. | 51.60 | 22 | 73 | 73 | 37 | 54 |
| Conexeu Sciences Inc. | 29.76 | 5 | 45 | 9 | 32 | 58 |
| Insight Molecular Diagnostics Inc. | 43.78 | 0 | 47 | 34 | 93 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -7.06 |
| P/B ratio | -2.49 |
EEarnings
| Trailing EPS | ₹-123.13 |
| Forward EPS | ₹146.33 |
NNitro
| Price | 869.48 |
| 52-week high | 1813.32 |
| 52-week low | 371.28 |
| Fall from 52-week high | 52.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.27 |
AAnchor
| Beta (price swings) | 0.22 |
| Market cap | ₹872 Cr |
| Insider holding | 16.80% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Atara Biotherapeutics, Inc.'s PosiPenta score?
Atara Biotherapeutics, Inc.'s PosiPenta is 55.33 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Atara Biotherapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Atara Biotherapeutics, Inc. is Grid #208 of 837 in the Healthcare sector in United States, and Grid #1,215 of 4,000 in United States.
Which PosiPenta pillar is strongest for Atara Biotherapeutics, Inc.?
Torque (durability), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Atara Biotherapeutics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Atara Biotherapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.12 points, from 52.21 to 55.33.
PositoAI is for research and education only and is not investment advice.